NEW YORK, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

7980. The investigation concerns whether HealthEquity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from ...

Buying $1000 In HQY: If an investor had bought $1000 of HQY stock 10 years ago, it would be worth $3,618.59 today based on a ...

Mizuho started coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price for the company. Finally, JMP Securities ...

In the last three months, 4 analysts have published ratings on HealthEquity HQY, offering a diverse range of perspectives from bullish to bearish. The table below provides a concise overview of ...

HealthEquity logged higher revenue in its fiscal fourth quarter on more user accounts, though its outlook underwhelmed investors. The Draper, Utah., health-savings account custodian on Tuesday ...

Over the past few days HealthEquity (NASDAQ: HQY) shares have been rather sickly. The health savings account (HSA) specialist's stock was rocked by a disappointing earnings report, and as a result ...

Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised ...